Profile data is unavailable for this security.
About the company
Alaunos Therapeutics, Inc. is a clinical-stage oncology-focused cell therapy company. The Company is focused on exploring strategic alternatives, including, but not limited to, an acquisition, merger, reverse merger, sale of assets, strategic partnerships, capital raises or other transactions. Separately, the Company is evaluating several potential in-licensing opportunities in obesity, oncology and virology.
- Revenue in USD (TTM)5.00k
- Net income in USD-35.14m
- Incorporated2005
- Employees1.00
- LocationAlaunos Therapeutics Inc2617 Bissonnet St, Suite 225HOUSTON 77005United StatesUSA
- Phone+1 (617) 259-1970
- Fax+1 (617) 241-2855
- Websitehttps://alaunos.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| KALA BIO Inc | 0.00 | -42.20m | 19.74m | 43.00 | -- | 2.58 | -- | -- | -17.94 | -17.94 | 0.00 | 2.72 | 0.00 | -- | -- | 0.00 | -59.12 | -57.83 | -77.62 | -69.32 | -- | 57.06 | -- | -1,553.61 | -- | -12.78 | 0.82 | -- | -100.00 | -- | 5.85 | -- | -17.31 | -- |
| Inhibitor Therapeutics Inc | 0.00 | -3.03m | 20.30m | 3.00 | -- | 3.84 | -- | -- | -0.0176 | -0.0176 | 0.00 | 0.0307 | 0.00 | -- | -- | 0.00 | -28.92 | 27.48 | -30.91 | 32.70 | -- | -- | -- | -- | -- | -- | 0.00 | 0.00 | -- | -- | -125.39 | -- | -- | -- |
| CERo Therapeutics Holdings Inc | 0.00 | -2.54m | 20.32m | 8.00 | -- | -- | -- | -- | -0.3796 | -0.3796 | 0.00 | -0.9226 | 0.00 | -- | -- | 0.00 | -9.96 | -- | -33.80 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -279.82 | -- | -- | -- |
| MEI Pharma Inc | 72.65m | 19.84m | 20.39m | 46.00 | 1.03 | 0.3427 | 1.01 | 0.2807 | 2.98 | 2.98 | 10.90 | 8.93 | 0.6425 | -- | 25.47 | 1,579,304.00 | 17.55 | -25.31 | 20.31 | -28.59 | -- | -- | 27.32 | -122.05 | -- | -- | 0.00 | -- | 19.95 | 97.56 | 41.53 | -- | -- | -- |
| Evaxion Biotech A/S - ADR | 73.00k | -22.13m | 20.60m | 49.00 | -- | -- | -- | 282.18 | -81.29 | -81.29 | 0.2665 | -1.25 | 0.0042 | -- | 0.091 | 1,489.80 | -126.74 | -100.11 | -183.85 | -131.65 | -- | -- | -30,308.22 | -131,560.30 | -- | -30.92 | 1.77 | -- | -- | -- | 4.51 | -- | 65.53 | -- |
| AIM ImmunoTech Inc | 202.00k | -28.96m | 20.60m | 26.00 | -- | 2.08 | -- | 101.98 | -0.595 | -0.595 | 0.0042 | 0.2084 | 0.0068 | -- | 0.1413 | 7,769.23 | -96.75 | -45.64 | -116.18 | -48.35 | 79.21 | -231.75 | -14,337.62 | -11,695.01 | -- | -- | 0.00 | -- | 43.26 | -11.26 | -48.94 | -- | 35.73 | -- |
| Serina Therapeutics Inc | 142.00k | -14.80m | 20.76m | 4.00 | -- | 1.64 | -- | 146.17 | -13.72 | -13.72 | 0.1316 | 5.07 | 0.0187 | -- | 4.66 | 35,500.00 | -194.80 | -194.46 | -- | -- | 71.83 | 85.80 | -10,430.28 | -2,347.36 | -- | -2.03 | 0.4489 | -- | 317.65 | -36.69 | -41.49 | -- | -- | -- |
| Alaunos Therapeutics Inc | 5.00k | -35.14m | 20.82m | 1.00 | -- | 3.30 | -- | 4,163.25 | -2.20 | -2.20 | 0.0003 | 0.3939 | 0.0001 | -- | 2.00 | 5,000.00 | -96.01 | -74.83 | -149.28 | -89.57 | -- | -- | -702,800.00 | -10,508.06 | -- | -14.83 | 0.00 | -- | -99.83 | -49.08 | 6.86 | -- | -15.56 | -- |
| Eom Pharmaceutical Holdings Inc | 0.00 | -4.93m | 20.84m | 3.00 | -- | -- | -- | -- | -0.0435 | -0.0435 | 0.00 | -0.0212 | -- | -- | -- | 0.00 | -- | -126.34 | -- | -171.37 | -- | -- | -- | -- | -- | -- | 7.41 | -- | -- | -- | -254.37 | -- | -- | -- |
| Biomx Inc | 0.00 | -26.17m | 21.20m | 58.00 | -- | 5.73 | -- | -- | -0.5433 | -0.5433 | 0.00 | 0.067 | 0.00 | -- | -- | 0.00 | -74.18 | -- | -101.74 | -- | -- | -- | -- | -- | -- | -21.95 | 0.7841 | -- | -- | -- | 7.59 | -- | -- | -- |
| Synlogic Inc | 3.37m | -57.28m | 21.43m | 6.00 | -- | 0.3963 | -- | 6.36 | -11.41 | -11.41 | 0.6581 | 4.64 | 0.0362 | -- | -- | 561,833.30 | -61.46 | -40.57 | -74.45 | -43.82 | -- | -- | -1,699.26 | -3,245.93 | -- | -- | 0.00009 | -- | 185.68 | 5.99 | 13.40 | -- | -48.05 | -- |
| Flora Growth Corp | 76.07m | -47.36m | 21.67m | 97.00 | -- | 2.36 | -- | 0.2848 | -6.62 | -7.97 | 10.04 | 0.7167 | 1.45 | 6.76 | 31.13 | 784,237.10 | -89.22 | -- | -130.91 | -- | 23.32 | -- | -61.35 | -- | 0.7897 | -- | 0.2317 | -- | 127.75 | -- | -1.87 | -- | -- | -- |
| TherapeuticsMD Inc | 1.30m | -7.70m | 21.68m | 1.00 | -- | 0.7403 | -- | 16.65 | -0.7466 | -1.00 | 0.1249 | 2.54 | 0.0195 | -- | -- | 1,302,000.00 | -11.51 | -53.35 | -19.23 | -111.61 | 100.00 | 86.67 | -591.32 | -236.57 | -- | -- | 0.00 | -- | -98.14 | -39.53 | -816.85 | -- | -- | -- |
| OncoCyte Corp | 1.50m | -25.80m | 22.01m | 43.00 | -- | 1.07 | -- | 14.64 | -3.08 | -3.47 | 0.1869 | 3.10 | 0.0172 | -- | 1.20 | 34,953.49 | -28.41 | -35.11 | -31.93 | -39.71 | 27.48 | -- | -1,653.69 | -2,373.36 | -- | -146.07 | 0.00 | -- | 56.89 | -- | -34.84 | -- | 55.41 | -- |
| NRX Pharmaceuticals Inc | 0.00 | -30.16m | 22.02m | 2.00 | -- | -- | -- | -- | -2.95 | -2.95 | 0.00 | -0.1398 | 0.00 | -- | -- | -- | -182.00 | -120.57 | -- | -168.40 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | 24.14 | -- | -- | -- |
| Zivo Bioscience Inc | 27.65k | -7.78m | 22.14m | 8.00 | -- | -- | -- | 800.85 | -4.62 | -4.62 | 0.0163 | -0.9259 | 0.0206 | -- | -- | 3,456.25 | -580.66 | -376.60 | -- | -- | 41.99 | -- | -28,127.23 | -96,315.32 | -- | -97.39 | -- | -- | -- | -- | 11.07 | -- | -- | -- |
Data as of May 03 2024. Currency figures normalised to Alaunos Therapeutics Inc's reporting currency: US Dollar USD
15.27%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| MSD Partners LPas of 31 Dec 2023 | 1.01m | 6.30% |
| The Vanguard Group, Inc.as of 31 Dec 2023 | 624.24k | 3.89% |
| Discovery Capital Management LLCas of 31 Dec 2023 | 266.79k | 1.66% |
| BlackRock Fund Advisorsas of 31 Dec 2023 | 222.37k | 1.39% |
| Geode Capital Management LLCas of 31 Dec 2023 | 150.42k | 0.94% |
| SSgA Funds Management, Inc.as of 31 Dec 2023 | 50.34k | 0.31% |
| Securities America Advisors, Inc.as of 31 Dec 2023 | 36.99k | 0.23% |
| Squarepoint OPS LLCas of 31 Dec 2023 | 29.75k | 0.19% |
| Commerce Bank (Investment Management)as of 31 Dec 2023 | 29.13k | 0.18% |
| Northern Trust Investments, Inc.(Investment Management)as of 31 Dec 2023 | 29.04k | 0.18% |
More ▼
Data from 31 Dec 2023 - 31 Dec 2023Source: FactSet Research Systems Inc.
